Kaleido Biosciences (OTC: KLDO)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Kaleido Biosciences (OTCPK: KLDO) through any online brokerage.
There are no as such competitors for Kaleido Biosciences.
The latest price target for Kaleido Biosciences (OTCPK: KLDO) was reported by Chardan Capital on Monday, April 4, 2022. The analyst firm set a price target for 1.70 expecting KLDO to rise to within 12 months (a possible 3048.15% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Kaleido Biosciences (OTCPK: KLDO) is $0.054 last updated July 6, 2022, 7:53 PM UTC.
There are no upcoming dividends for Kaleido Biosciences.
Kaleido Biosciences’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Kaleido Biosciences.
Kaleido Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.